Evidence map›Paper›PMID 40603056›Full record

ReviewInternal medicine (Tokyo, Japan)2025

Concurrent Fulminant Myocarditis and Severe Rhabdomyolysis in COVID-19-related Multisystem Inflammatory Syndrome in Adults: A Case Report and Review of the Literature.

Ryohei Ono, Togo Iwahana, Kaoruko Aoki, Hirotoshi Kato, Noriyuki Hattori, Taku Oshima, Yusuke Kouchi, Rei Hashimoto, Takashi Kishimoto, Jun-Ichiro Ikeda and 1 more

Abstract readCase ReportsReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Internal medicine (Tokyo, Japan), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ryohei OnoDepartment of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Japan.
Togo IwahanaDepartment of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Japan.
Kaoruko AokiDepartment of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Japan.
Hirotoshi KatoDepartment of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Japan.
Noriyuki HattoriDepartment of Emergency and Critical Care Medicine, Chiba University Graduate School of Medicine, Japan.
Taku OshimaDepartment of Emergency and Critical Care Medicine, Chiba University Graduate School of Medicine, Japan.
Yusuke KouchiDepartment of Molecular Pathology, Chiba University Graduate School of Medicine, Japan.
Rei HashimotoDepartment of Pathology, Chiba University Hospital, Japan.
Takashi KishimotoDepartment of Molecular Pathology, Chiba University Graduate School of Medicine, Japan.
Jun-Ichiro IkedaDepartment of Pathology, Chiba University Hospital, Japan.
Yoshio KobayashiDepartment of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This case report describes a 47-year-old woman with coronavirus disease 2019 (COVID-19)-related multisystem inflammatory syndrome in adults (MIS-A), who presented with fulminant myocarditis and severe rhabdomyolysis. Despite the absence of severe respiratory symptoms, the patient showed remarkable myocardial and leg edema with significant systemic inflammation and elevated creatine kinase levels after the COVID-19 infection. The patient required venoarterial extracorporeal membrane oxygenation (VA-ECMO) and Impella CP

Indexed as

MyocarditisRhabdomyolysisSystemic Inflammatory Response SyndromeCOVID-19Extracorporeal Membrane OxygenationFemaleHumansMiddle AgedPandemicsSARS-CoV-2ECMOECPELLAImpellaMIS-ArhabdomyolysisSARS-CoV-2

Identifiers

PMID40603056
PMCPMC12287584

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.